In the signature model, gene pairs (BIRC3|RGS16 and HES1|ITM2C) harbored the highest coefficients and presented positive and negative effects on the prognosis of NSCLC patients, respectively. This evidence concerns the gene RGS16 and non-small cell lung carcinoma.